Acadia Healthcare Q3 Earnings Call Highlights
Acadia Healthcare (ACHC) reported Q3 revenue guidance of $3.44B-$3.46B, adjusted EBITDA of $615M-$625M, and adjusted EPS of $1.70-$1.80. The company lowered its full-year capital expenditure forecast to $210M-$230M. It added 220 licensed beds in Q3, with plans for further facility expansions. Medicaid work requirements and legal expenses were discussed, with minimal expected impact. ACHC operates behavioral healthcare facilities in the U.S. and U.K.
How this was made

The 30-second read
Why it matters
The earnings release provides fresh guidance and cash‑flow metrics that were not previously public.
Market read
First‑report earnings and guidance for Q3, affecting valuation and sector sentiment.
What to watch
Potential incremental EBITDA from Florida and Ohio programs could offset guidance cuts if approved.
Background
Acadia Healthcare (NASDAQ:ACHC) provides psychiatric and addiction treatment services across the U.S. and the U.K.
Ticker impact
Q3 earnings released with revenue $3.44‑$3.46B, adjusted EBITDA $615‑$625M and lowered full‑year capex guidance.
likely downside as market prices in lower capex outlook
Earnings are in line but capex reduction signals slower growth, prompting investors to trim positions.
Market effects
Behavioral health sector may see modest pressure as Acadia signals slower expansion.
U.S. healthcare investors may adjust exposure to specialty providers.
Limited; primarily affects U.S. listed behavioral health stocks.
Counterpoint
Capex cut could improve cash flow and reduce leverage, offering a buying opportunity if the market overreacts.
Key entities
- CompanyAcadia Healthcare
Provider of behavioral health services.
- ExecutiveDavid Duckworth
CEO who discussed guidance and capex.



